|
ZNF720 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.663700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.858020E-01 |
| Normal-vs-Stage2 |
4.836400E-01 |
| Normal-vs-Stage3 |
2.175500E-03 |
| Normal-vs-Stage4 |
1.903720E-02 |
| Stage1-vs-Stage2 |
6.742000E-01 |
| Stage1-vs-Stage3 |
9.318800E-03 |
| Stage1-vs-Stage4 |
1.610010E-01 |
| Stage2-vs-Stage3 |
3.635600E-02 |
| Stage2-vs-Stage4 |
1.512190E-01 |
| Stage3-vs-Stage4 |
5.862200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.983700E-02 |
| Normal-vs-AfricanAmerican |
1.485440E-01 |
| Normal-vs-Asian |
3.235800E-01 |
| Caucasian-vs-AfricanAmerican |
8.538800E-01 |
| Caucasian-vs-Asian |
5.116800E-01 |
| AfricanAmerican-vs-Asian |
5.483600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.399500E-02 |
| Normal-vs-Female |
7.151600E-02 |
| Male-vs-Female |
8.027200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.063800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.752300E-02 |
| Normal-vs-Age(61-80Yrs) |
2.754300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.196100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.670200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.019000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.402400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.375600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.053400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.375400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.319540E-02 |
| Classical-VS-Follicular |
7.121200E-01 |
| Classical-VS-Other |
5.995000E-01 |
| Classical-VS-Normal |
1.757590E-01 |
| Tall-VS-Follicular |
3.980100E-02 |
| Tall-VS-Other |
4.018400E-01 |
| Tall-VS-Normal |
1.135570E-03 |
| Follicular-VS-Other |
7.635000E-01 |
| Follicular-VS-Normal |
1.645640E-01 |
| Other-VS-Normal |
2.555400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.458200E-02 |
| Normal-vs-N1 |
5.387700E-02 |
| N0-vs-N1 |
7.495000E-01 |
|
|
